Comment: Osimertinib for EGFR-mutation positive NSCLC
Dr Pilar Garrido - University Hospital Ramón y Cajal, Madrid, Spain
28 Sep 2019
Nivolumab plus ipilimumab combination offers chemotherapy-free option for advanc...
Prof Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne, Switze...
28 Sep 2019
Front-line osimertinib significantly lengthens overall survival in EGFR-mutation...
Prof Suresh Ramalingam - Winship Cancer Institute of Emory University, Atlanta, ...
28 Sep 2019
Comment: Immunotherapy combination for advanced NSCLC
Dr Marina Garassino - National Tumour Institute, Milan, Italy
28 Sep 2019
Comment: Front-line osimertinib significantly lengthens overall survival in EGFR...
Dr Marina Garassino - National Tumour Institute, Milan, Italy
28 Sep 2019
Important developments in radiation oncology
Dr Ana Botero - Memorial Healthcare System, Hollywood, FL, USA
26 Jul 2019
New standard of care for lung cancer patients with EGFR mutations
Dr Gelenis Domingo - Memorial Healthcare System, Hollywood, FL, USA
26 Jul 2019
Lung cancer screening and the management of the pulmonary nodule
Dr Mark Block - Memorial Healthcare System, Hollywood, FL, USA
26 Jul 2019
Immunotherapy for lung cancer before surgery
Dr. Luis Raez - Memorial Cancer Institute, Florida, USA
19 Jul 2019
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in pa...
Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA
10 Jul 2019
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast ...
Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan
10 Jul 2019
Gene expression in primary non-small cell lung cancer as a predictor of brain me...
Dr Jair Bar - Sheba Medical Center, Tel Hashomer, Israel
10 Jul 2019
